Hrt Financial LP Tiziana Life Sciences LTD Transaction History
Hrt Financial LP
- $15.7 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding TLSA
# of Institutions
32Shares Held
993KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA246KShares$275,2080.0% of portfolio
-
Morgan Stanley New York, NY111KShares$124,1300.0% of portfolio
-
Hsbc Holdings PLC London, X0105KShares$118,0080.0% of portfolio
-
Zhang Financial LLC93.2KShares$104,3690.0% of portfolio
-
Kovitz Investment Group Partners, LLC79.4KShares$88,8880.0% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $115M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...